Histological evaluation of the adrenal glands of seven dogs with hyperadrenocorticism treated with trilostane

No abstract is available for this paper.

• Publication year

  2007

• Venue

  The Veterinary Record

• Publication date

  2007-02-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1136/vr.160.7.219PMID 17308018
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumors of the Endocrine Glands

  2008cited by this paper
• Adrenocorticotropic hormone levels in dogs with pituitary-dependent hyperadrenocorticism following trilostane therapy

  2004cited by this paper
• Effect of trilostane on serum concentrations of aldosterone, cortisol, and potassium in dogs with pituitary-dependent hyperadrenocorticism.

  2004cited by this paper
• Adrenal necrosis in a dog receiving trilostane for the treatment of hyperadrenocorticism.

  2004cited by this paper
• Trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism.

  2003cited by this paper
• Use of trilostane for the treatment of pituitary-dependent hyperadrenocorticism in a cat.

  2003cited by this paper
• Trilostane treatment of a dog with functional adrenocortical neoplasia.

  2003cited by this paper
• Changes in ultrasonographic appearance of adrenal glands in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane.

  2003cited by this paper
• The ectopic expression of the gastric inhibitory polypeptide receptor is frequent in adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia, but rare in unilateral tumors.

  2002cited by this paper
• Morphological and Biochemical Aspects of Apoptosis, Oncosis and Necrosis

  2002cited by this paper
• Trilostane treatment of 78 dogs with pituitary-dependent hyperadrenocorticism

  2002cited by this paper
• Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane.

  2002cited by this paper
• [Illicit hormone receptors in adrenal Cushing's syndrome].

  2001cited by this paper
• Genetic background of adrenocortical tumor development

  2001cited by this paper
• Genetic background of adrenocortical tumor development

  2001cited by this paper
• Modulation of IL-18 Production in the Adrenal Cortex following Acute ACTH or Chronic Corticosterone Treatment

  2000cited by this paper
• Aponecrosis: Morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis

  2000cited by this paper
• Ultrasonographic characteristics of both adrenal glands in 15 dogs with functional adrenocortical tumors.

  1999cited by this paper
• Apoptosis and necrosis: different execution of the same death.

  1999cited by this paper
• Cushing’s syndrome due to ACTH-independent bilateral adrenocortical macronodular hyperplasia

  1997cited by this paper
• Bilateral massive adrenal hemorrhage.

  1995influential reference
• Tumor necrosis factor alpha cooperates with interleukin 3 in the recruitment of a primitive subset of human CD34+ progenitors

  1993cited by this paper
• Adrenal Gland: Chemically Induced Structural and Functional Changes in the Cortex

  1989cited by this paper
• Macronodular adrenocortical hyperplasia in long-standing Cushing's disease.

  1984cited by this paper
• Adrenocortical hemorrhagic necrosis: the role of catecholamines and retrograde medullary-cell embolism.

  1981cited by this paper
• Cortical hyperplasia of the adrenal gland in the dog.

  1980cited by this paper
• Adrenal cortico-medullary junction necrosis: a morphologic marker for hypotension.

  1979cited by this paper
• Treatment of Cushing's syndrome with trilostane (WIN 24,540), an inhibitor of adrenal steroid biosynthesis.

  1978cited by this paper
• Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics

  1972cited by this paper
• The Adrenal Gland in Dogs with Hyperadrenocorticalism; A Pathologic Study

  1971cited by this paper
• Textbook of Endocrinology

  1956cited by this paper
• Adrenal necrosis and thrombosis in routine necropsies.

  1955cited by this paper
• A study of the role of adrenocorticotropic hormone (ACTH) in the pathogenesis of tubular degeneration of the adrenals.

  1953cited by this paper
• The Endocrine Glands

  1940cited by this paper

• Pneumoperitoneum in two cats treated with trilostane for hypercortisolism

  2025cites this paper
• Trilostane: Beyond Cushing’s Syndrome

  2025cites this paper
• Adrenocortical hypoperfusion detected by contrast-enhanced ultrasound in a dog with trilostane-induced hypoadrenocorticism.

  2023cites this paper
• Iatrogenic symptomatic hypoadrenocorticism after treatment with trilostane for hyperadrenocorticism in dogs: eight cases (2008-2019).

  2023cites this paper
• Case report: Successful medical management of adrenocortical carcinoma with metastasis in a Maltese dog

  2023cites this paper
• Isolated hypoaldosteronism managed by DOCP in a dog with chronic kidney disease and hypercortisolism

  2022cites this paper
• Adrenal glands

  2021cites this paper
• Tumors of the Endocrine System

  2020cites this paper
• Endocrine Pharmacotherapeutics

  2019cites this paper
• Taming trilostane: past and future

  2019cites this paper
• Melanocortin 2 receptor antagonists in canine pituitary-dependent hypercortisolism: in vitro studies

  2018cites this paper
• Treating canine Cushing's syndrome: Current options and future prospects.

  2018cites this paper
• Steroidogenic factor-1 inverse agonists as a treatment option for canine hypercortisolism: in vitro study.

  2018cites this paper
• Lesões de adrenais em 300 cães

  2018cites this paper
• Update on the use of trilostane in dogs.

  2018cites this paper
• Successful management of lymphangiosarcoma in a puppy using a tyrosine kinase inhibitor.

  2018cites this paper
• Incidence and risk factors for hypoadrenocorticism in dogs treated with trilostane.

  2017cites this paper
• What Is Your Diagnosis?

  2016cites this paper
• Evaluation of baseline cortisol concentration to monitor efficacy of twice-daily administration of trilostane to dogs with pituitary-dependent hyperadrenocorticism: 22 cases (2008-2012).

  2016cites this paper
• Comparison of 2 Doses for ACTH Stimulation Testing in Dogs Suspected of or Treated for Hyperadrenocorticism

  2016cites this paper
• Zusammenhang zwischen klinischer Symptomatik,Laborparametern und Ergebnissen des Adrenokortikotropen-Hormon-Stimulationstests bei Hunden mit Hyperadrenokortizismus unter Therapie mit Trilostan

  2015cites this paper
• Chapter 12 – Hypoadrenocorticism

  2015cites this paper
• Chapter 15 – Adrenal Glands

  2015cites this paper
• Chapter 10 – Canine Hyperadrenocorticism

  2015cites this paper
• Effect of Trilostane and Mitotane on Aldosterone Secretory Reserve in Dogs with Pituitary‐Dependent Hyperadrenocorticism

  2014cites this paper
• Hyperadrenocorticism in Dogs

  2014cites this paper
• Trilostane - the good and the bad

  2014cites this paper
• THE HISTOPATHOLOGICAL EVALUATION OF DOGS ADRENAL GLANDS

  2014cites this paper
• Comparison of two treatment regimens with trilostane in dogs with pituitary-dependent hyperadrenocorticism.

  2013cites this paper
• Trilostane therapy for treatment of spontaneous hyperadrenocorticism in cats: 15 cases (2004-2012).

  2013cites this paper
• Efficacy of low- and high-dose trilostane treatment in dogs (< 5 kg) with pituitary-dependent hyperadrenocorticism.

  2013cites this paper
• Diagnosis of hypoadrenocorticism in dogs

  2013cites this paper
• Das Cushing-Syndrom beim Hund – Klinik, Diagnose und Therapie

  2012cites this paper
• A comparison of once and twice daily administration of trilostane to dogs with hyperadrenocorticism

  2012cites this paper
• Trilostane dose versus body weight in the treatment of naturally occurring pituitary-dependent hyperadrenocorticism in dogs.

  2012cites this paper
• Vergleich zwischen einmal und zweimal täglicher Applikation von Trilostan bei Hunden mit Hyperadrenokortizismus

  2012cites this paper
• Assessment of Hypercoagulability in Canine Pituitary-Dependent Hyperadrenocorticism

  2012cites this paper
• Canine iatrogenic persistent hypoadrenocorticism after short-term treatment of hyperadrenocorticism with trilostane - a case report

  2011cites this paper
• Evaluation of twice-daily lower-dose trilostane treatment administered orally in dogs with naturally occurring hyperadrenocorticism.

  2011cites this paper
• Determination of the concentrations of trilostane and ketotrilostane that inhibit ex vivo canine adrenal gland synthesis of cortisol, corticosterone, and aldosterone.

  2011cites this paper
• Adrenocorticotropic hormone, but not trilostane, causes severe adrenal hemorrhage, vacuolization, and apoptosis in rats.

  2011influential citation
• CUSHING ’ S DISEASE IN DOGS : RECOMMENDED DIAGNOSTIC

  2010cites this paper
• Recent developments in canine Cushing`s syndrome

  2010cites this paper
• Canine Hyperadrenocorticism: Part 2

  2010cites this paper
• Canine hypoadrenocorticism: part II.

  2010cites this paper
• Canine hypoadrenocorticism: part I.

  2010cites this paper
• Trilostane in dogs.

  2010influential citation
• Effects of trilostane on the pituitary-adrenocortical and renin-aldosterone axis in dogs with pituitary-dependent hypercortisolism.

  2010cites this paper
• Trilostane-induced inhibition of cortisol secretion results in reduced negative feedback at the hypothalamic-pituitary axis.

  2009cites this paper
• Urinary corticoid: creatinine ratios in dogs with pituitary-dependent hypercortisolism during trilostane treatment.

  2009cites this paper
• Computed tomographic adrenal gland quantification in canine adrenocorticotroph hormone-dependent hyperadrenocorticism.

  2008cites this paper
• Evaluation of twice-daily, low-dose trilostane treatment administered orally in dogs with naturally occurring hyperadrenocorticism.

  2008cites this paper
• WEDNESDAY SLIDE

  year unknowncites this paper
• hyper-Determination of the concentrations of trilostane and ketotrilostane that inhibit ex vivo canine adrenal gland synthesis of cortisol, corticosterone, and aldosterone

  year unknowncites this paper